Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.
As of May 2023 Biogen has a market cap of $43.23 Billion. This makes Biogen the world's 378th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2023 | $43.23 B | 8.42% |
2022 | $39.87 B | 13.15% |
2021 | $35.24 B | -6.47% |
2020 | $37.67 B | -27.11% |
2019 | $51.69 B | -12.89% |
2018 | $59.34 B | -11.92% |
2017 | $67.37 B | 9.19% |
2016 | $61.69 B | -7.87% |
2015 | $66.96 B | -15.89% |
2014 | $79.62 B | 20.51% |
2013 | $66.07 B | 90.8% |
2012 | $34.62 B | 29.53% |
2011 | $26.73 B | 65.75% |
2010 | $16.12 B | 9.68% |
2009 | $14.70 B | 7.18% |
2008 | $13.71 B | -18.49% |
2007 | $16.83 B | 1.49% |
2006 | $16.58 B | 7.9% |
2005 | $15.36 B | -32.09% |
2004 | $22.63 B |
On May 30th, 2023 the market cap of Biogen was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $401.16 B | 827.92% | ๐บ๐ธ USA |
![]() Pfizer PFE | $208.93 B | 383.27% | ๐บ๐ธ USA |
![]() AbbVie ABBV | $240.71 B | 456.80% | ๐บ๐ธ USA |
![]() Amgen AMGN | $116.76 B | 170.09% | ๐บ๐ธ USA |
![]() Sanofi SNY | $127.90 B | 195.85% | ๐ซ๐ท France |
![]() Gilead Sciences GILD | $95.21 B | 120.23% | ๐บ๐ธ USA |
![]() Illumina ILMN | $30.75 B | -28.87% | ๐บ๐ธ USA |
![]() Acorda Therapeutics
ACOR | $14.89 M | -99.97% | ๐บ๐ธ USA |
![]() Qiagen QGEN | $10.32 B | -76.11% | ๐ณ๐ฑ Netherlands |
![]() Bio-Rad Laboratories BIO | $11.21 B | -74.05% | ๐บ๐ธ USA |